The medicines regulator has urged patients to return Emerade 300 and 500 microgram adrenaline pens to their local pharmacies because some may fail to or prematurely activate if dropped.
Patients, or carers of patients, should “immediately” contact their GP, obtain a prescription for, and be supplied with, an alternative brand before returning the Emerade auto-injector pens, the Medicines and Healthcare products Regulatory Agency (MHRA) said.
